Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.
- DOI
- 10.1007/s00415-026-14112-5
- Published
- 2026 Sep 12
- Container
- Journal of neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00415-026-14112-5,
title = {Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.},
author = {Grétarsdóttir HM and Cunningham JL and Rasmusson A and Burman J and Kultima K and Paucar M and Svenningsson P and Constantinescu R and Niemelä V},
year = {2026},
journal = {Journal of neurology},
doi = {10.1007/s00415-026-14112-5},
url = {https://doi.org/10.1007/s00415-026-14112-5}
}RIS
TY - JOUR TI - Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression. AU - Grétarsdóttir HM AU - Cunningham JL AU - Rasmusson A AU - Burman J AU - Kultima K AU - Paucar M AU - Svenningsson P AU - Constantinescu R AU - Niemelä V PY - 2026 JO - Journal of neurology DO - 10.1007/s00415-026-14112-5 UR - https://doi.org/10.1007/s00415-026-14112-5 ER -
APA
HM, G., JL, C., A, R., J, B., K, K., M, P., P, S., R, C., & V, N. (2026). Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.. Journal of neurology. https://doi.org/10.1007/s00415-026-14112-5
Source records
- pubmed · retrieved 2026-09-25T12:47:45.177Z